Editorial: a paradigm shift in NUDT15 assessment-towards predictive and personalised medicine in Crohn's disease?
Aliment Pharmacol Ther
.
2022 Mar;55(6):740-741.
doi: 10.1111/apt.16798.
Authors
Rupa Banerjee
1
,
Nalini Raghunathan
1
Affiliation
1
Department of Inflammatory Bowel Disease, Asian Institute of Gastroenterology, Hyderabad, India.
PMID:
35245954
DOI:
10.1111/apt.16798
No abstract available
Publication types
Editorial
Comment
MeSH terms
Azathioprine
Crohn Disease* / diagnosis
Crohn Disease* / drug therapy
Crohn Disease* / genetics
Humans
Leukopenia*
Precision Medicine
Substances
Azathioprine